Greenberg Traurig’s Life Sciences & Medical Technology Group Hosts Two Webinars During 2021 JP Morgan Healthcare Conference

Share Article

For the seventh consecutive year, Greenberg Traurig, LLP’s Global Life Sciences & Medical Technology Group will host two events in conjunction with the JP Morgan Healthcare Conference, taking place virtually Jan. 11-14.

For the seventh consecutive year, Greenberg Traurig, LLP’s Global Life Sciences & Medical Technology Group will host two events in conjunction with the JP Morgan Healthcare Conference, taking place virtually Jan. 11-14.

On Jan. 11, Greenberg Traurig Shareholders Fiona Adams, co-chair of the Global Corporate Practice and managing shareholder of the London office, and Wayne H. Elowe, co-chair of the Global Life Sciences & Medical Technology Group and the Atlanta office’s Corporate Practice, will moderate the panel “Biotech and Pharma Trends: Deals, Financings and Vaccines.” The webinar will feature industry leaders discussing the latest trends in biotechnology and pharmaceuticals, including deals, financings, and vaccines. Webinar panelists will include:

  • Alan Crane, Entrepreneur Partner, Polaris Partners
  • Shaun Grady, Vice-President Business Development Operations, AstraZeneca
  • Adam Koppel, M.D., Ph.D., Managing Director, Bain Capital
  • Richard Yu, Head of Business Development and Licensing, Huadong Medicine

On Jan. 12, David J. Dykeman, co-managing Shareholder of the Boston office and co-chair of the Global Life Sciences & Medical Technology Group, and Shareholder Ginger Pigott, vice chair of the Pharmaceutical, Medical Device & Health Care Litigation Practice, will moderate the panel “Trends in Medical Devices, Digital Health, and AI.” The webinar will include industry leaders discussing the latest trends in medical devices, digital health, and artificial intelligence. Webinar panelists will include:

  • Casper de Clercq, General Partner, Norwest Venture Partners
  • Marie O’Malley, Senior Director Supplier Outreach, Medtronic
  • Jeremy Sohn, Global Head, Digital Development and BD & Licensing, Novartis
  • Angela Wang, Senior Vice President, Neusoft

About Greenberg Traurig’s Life Sciences & Medical Technology Group: Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.

About Greenberg Traurig: Greenberg Traurig, LLP (GT), has approximately 2200 attorneys in 40 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. The firm is net carbon neutral with respect to its office energy usage and Mansfield Rule 3.0 Certified. Web: http://www.gtlaw.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Lourdes Brezo Martinez
Visit website